Zdeňka Ellederová

ORCID: 0000-0001-6695-6345
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetic Neurodegenerative Diseases
  • Retinal Development and Disorders
  • Mitochondrial Function and Pathology
  • CRISPR and Genetic Engineering
  • Muscle Physiology and Disorders
  • Retinal and Macular Surgery
  • Neuroscience and Neural Engineering
  • Virus-based gene therapy research
  • Reproductive Biology and Fertility
  • Pluripotent Stem Cells Research
  • Animal Genetics and Reproduction
  • Retinal Diseases and Treatments
  • RNA Interference and Gene Delivery
  • DNA Repair Mechanisms
  • Neurological disorders and treatments
  • Animal Behavior and Welfare Studies
  • Biochemical effects in animals
  • Pancreatic function and diabetes
  • Epigenetics and DNA Methylation
  • Advanced Drug Delivery Systems
  • Biotin and Related Studies
  • Microtubule and mitosis dynamics
  • Ubiquitin and proteasome pathways
  • Muscle activation and electromyography studies
  • Bee Products Chemical Analysis

Czech Academy of Sciences, Institute of Animal Physiology and Genetics
2016-2025

University of Edinburgh
2023

Oslo University Hospital
2022

University of Oslo
2022

Czech Academy of Sciences
2004-2021

Institute of Animal Physiology of the Slovak Academy of Sciences
2021

Discovery Institute
2019

Sanford Burnham Prebys Medical Discovery Institute
2014-2019

Huntington's disease (HD) is a fatal neurodegenerative disorder caused by CAG trinucleotide repeat expansion in the huntingtin gene. Previously, we showed strong reduction and prevention of neuronal dysfunction HD rodents using an engineered microRNA targeting human huntingtin, delivered via adeno-associated virus (AAV) serotype 5 vector with transgene encoding miRNA against HTT mRNA (AAV5-miHTT). One challenges as model diseases their relatively small brain, making successful translation to...

10.1016/j.ymthe.2018.06.021 article EN cc-by-nc-nd Molecular Therapy 2018-06-25

Abstract Clustered regularly interspaced short palindromic repeats-associated protein (CRISPR/Cas9) system has become a revolutionary tool for gene editing. Since viral delivery systems have significant side effects, and naked DNA is not an option, the nontoxic, non-viral of CRISPR/Cas9 components would significantly improve future therapeutic delivery. In this study, we aim at characterizing nanoparticles to deliver plasmid encoding CRISPR-Cas in eukaryotic cells vitro . complexed...

10.1038/s41598-020-61465-6 article EN cc-by Scientific Reports 2020-03-12

Spinocerebellar ataxia type 3 (SCA3), or Machado-Joseph disease (MJD), is a progressive neurodegenerative disorder caused by CAG expansion in the ATXN3 gene. The expanded repeat translated into prolonged polyglutamine ataxin-3 protein and accumulates within inclusions, acquiring toxic properties, which results degeneration of cerebellum brain stem. In current study, non-allele-specific silencing approach was investigated using artificial microRNAs engineered to target various regions gene...

10.1016/j.omtm.2019.10.008 article EN cc-by-nc-nd Molecular Therapy — Methods & Clinical Development 2019-10-28

In vitro maturation (IVM) of fully grown mammalian oocytes is characterized by initial germinal vesicle (GV) breakdown and rearrangement microtubule network during the first meiosis (MI), followed extrusion polar body block in metaphase second (MII). Only matured are capable undergoing fertilization initiation zygotic development. These observations mostly based on morphological evaluation; however, molecular events responsible for these processes not known. this study, we have launched...

10.1095/biolreprod.104.030304 article EN Biology of Reproduction 2004-10-20

Aims/Purpose: The study of long‐term survival transplanted retinal pigment epithelium (RPE) in animal models is very important for the development promising cell‐based therapy degenerative diseases such as age‐related macular degeneration (AMD) or retinitis pigmentosa. We hereby present xenogeneic implantation human iPSC‐RPEs into minipig eyes with a 6‐week follow‐up period. Methods: subretinal implantations hiPSC‐RPEs‐scaffolds were performed using 3‐port pars plana vitrectomy. character...

10.1111/aos.17365 article EN Acta Ophthalmologica 2025-01-01

Purpose: This study aimed to evaluate early-phase safety of subretinal application AAVanc80.CAG.USH1Ca1 (OT_USH_101) in wild-type (WT) pigs, examining the effects a vehicle control, low dose, and high dose. Methods: Twelve WT pigs (24 eyes) were divided into three groups: four each received bilateral injections either vehicle, dose (3.3 × 1010 vector genomes [vg] per eye), or (1.0 1011 vg eye). Total retinal thickness (TRT) was evaluated using optical coherence tomography function assessed...

10.1167/iovs.66.1.48 article EN cc-by-nc-nd Investigative Ophthalmology & Visual Science 2025-01-21

In late stages of inherited and acquired retinal diseases such as Stargardt disease (STGD) or dry age-related macular degeneration (AMD), loss pigment epithelia (RPE) cells subsequently photoreceptors in the area result a dramatic decline central visual function. Repopulating this with functional RPE may prevent progression photoreceptor loss. present study, viability, survival, integration human induced pluripotent stem cell (hiPSC)-derived (hiPSC-RPE) is assessed generated using...

10.1002/advs.202412301 article EN cc-by Advanced Science 2025-04-02

Glycation of proteins is often considered as a method to improve their functional properties for promising applications in wound healing. Furthermore, marked increase percentage radical scavenging activity the conjugates makes it an effective antioxidant synthetic strategy. A simple conjugation process was employed develop bovine serum albumin-dextran (BSA-dextran) using Maillard reaction. Higher electrophoretic mobility and surface charge prepared observed native PAGE electrophoresis zeta...

10.1039/d0ra09301g article EN cc-by-nc RSC Advances 2021-01-01

In this study, we performed proteomic analysis of porcine oocytes during in vitro maturation. Comparison at the initial and final stages meiotic division characterized candidate proteins that were differentially synthesized While biosynthesis many these was significantly decreased, found four with increased biosynthetic rate, which are supposed to play an essential role meiosis. Among them, ubiquitin C-terminal hydrolase-L1 (UCH-L1) identified by mass spectrometry. To study regulatory UCH-L1...

10.1530/rep-07-0079 article EN Reproduction 2007-09-21

<b><i>Background:</i></b> Huntington's disease is induced by CAG expansion in a single gene coding the huntingtin protein. The mutated (mtHtt) primarily causes degeneration of neurons brain, but it also affects peripheral tissues, including testes. <b><i>Objective:</i></b> We studied sperm and testes transgenic boars expressing N-terminal region human mtHtt. <b><i>Methods:</i></b> In this study, measures reproductive...

10.1159/000443665 article EN Neurodegenerative Diseases 2016-01-01

Recently developed therapeutic approaches for the treatment of Huntington's disease (HD) require preclinical testing in large animal models. The minipig is a suitable experimental because its gyrencephalic brain, body weight 70-100 kg, long lifespan, and anatomical, physiological metabolic resemblance to humans. Libechov transgenic model HD (TgHD) has proven useful proof concept developing new therapies. However, evaluate efficacy different therapies on progression, broader phenotypic...

10.1242/dmm.041319 article EN cc-by Disease Models & Mechanisms 2019-10-23

The development of primary human retinal pigmented epithelium (hRPE) for clinical transplantation purposes on biodegradable scaffolds is indispensable. We hereby report the results subretinal implantation hRPE cells nanofibrous membranes in minipigs.The hRPEs were collected from cadaver donor eyes and cultivated ultrathin carriers prepared via electrospinning poly(L-lactide-co-DL-lactide) (PDLLA). "Libechov" minipigs (12-36 months old) used study, supported by preoperative tacrolimus...

10.3390/biomedicines10030669 article EN cc-by Biomedicines 2022-03-14

Age-related macular degeneration (AMD) is the most frequent cause of blindness in developed countries. The replacement dysfunctional human retinal pigment epithelium (hRPE) cells by transplantation vitro-cultivated hRPE to affected area emerges as a feasible strategy for regenerative therapy. Synthetic biomimetic membranes arise powerful cell carriers, but biodegradability requirement, it also poses challenge due its limited durability. exhibit several characteristics that putatively respond...

10.3390/biomedicines12050966 article EN cc-by Biomedicines 2024-04-26

ABSTRACT Skeletal muscle wasting and atrophy is one of the more severe clinical impairments resulting from progression Huntington's disease (HD). Mitochondrial dysfunction may play a significant role in etiology HD, but specific condition mitochondria has not been widely studied during development HD. To determine skeletal early stages we analyzed quadriceps femoris 24-, 36-, 48- 66-month-old transgenic minipigs that expressed N-terminal portion mutated human huntingtin protein (TgHD)...

10.1242/dmm.038737 article EN cc-by Disease Models & Mechanisms 2019-07-01

Huntington's disease (HD) is an autosomal dominant affecting neurons predominantly in the striatum due to production of toxic huntingtin protein. Lowering concentration mutant a promising therapeutic approach, and suitable delivery system fascinating. Nanoparticles (NPs) minimize host immune response have no limit concerning number NPs administered. They are safe, targeted, effective for RNA therapeutics providing significant mode cross blood–brain barrier broad range clinical applications....

10.1021/acsanm.2c03936 article EN ACS Applied Nano Materials 2023-03-27

Purpose To assess the safety and feasibility of direct vitrectomy-sparing subretinal injection for gene delivery in a large animal model.

10.1080/02713683.2024.2343335 article EN Current Eye Research 2024-04-26

In this study, we document that the overall rate of protein synthesis decreases during in vitro maturation (IVM) pig oocytes despite enhanced formation 5' cap structure eIF4F. Within somatic/interphase cells, eIF4F complex correlates very well with rates translation, and is controlled primarily by availability binding eIF4E. We show eIF4E inhibitory protein, 4E-BP1, becomes phosphorylated IVM, which results gradual release from as documented immunoprecipitation analyses. Isoelectric focusing...

10.1002/mrd.20368 article EN Molecular Reproduction and Development 2005-01-01

Eukaryotic initiation factor 4E (eIF4E) plays an important role in mRNA translation by binding the 5'-cap structure of and facilitating recruitment to other factors 40S ribosomal subunit. eIF4E undergoes regulated phosphorylation on Ser-209 this is believed be for its factors. The findings showing that becomes gradually phosphorylated during vitro maturation (IVM) pig oocytes with a maximum metaphase II (M II) stage have been documented us recently (Ellederova et al., 2006). aim work was...

10.1002/mrd.20690 article EN Molecular Reproduction and Development 2007-02-08

<b><i>Background:</i></b> Huntington disease (HD) is an incurable neurodegenerative caused by the expansion of a polyglutamine sequence in gene encoding huntingtin (Htt) protein, which expressed almost all cells body. In addition to small animal models, new therapeutic approaches (including therapy) require large models as their brains are more realistic model for translational research. <b><i>Objective:</i></b> this study, we describe...

10.1159/000488592 article EN Neurodegenerative Diseases 2018-01-01

ABSTRACT Huntington's disease (HD) is a monogenic, progressive, neurodegenerative disorder with currently no available treatment. The Libechov transgenic minipig model for HD (TgHD) displays neuroanatomical similarities to humans and exhibits slow progression, therefore more powerful than mouse models the development of therapy. phenotypic characterization this still ongoing, it essential validate biomarkers monitor progression intervention. In study, behavioral phenotype (cognitive, motor...

10.1242/dmm.035949 article EN cc-by Disease Models & Mechanisms 2018-09-25
Coming Soon ...